These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Promising pharmacological agents in the management of acute spinal cord injury. Seidl EC Crit Care Nurs Q; 1999 Aug; 22(2):44-50. PubMed ID: 10646442 [TBL] [Abstract][Full Text] [Related]
3. New drugs for improving injury outcome in spinal cord injuries. Werner PC West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687 [No Abstract] [Full Text] [Related]
4. Promising pharmacological agents in the management of acute spinal cord injury. Seidl EC Pharm Pract Manag Q; 2000 Apr; 20(1):21-7. PubMed ID: 10947539 [TBL] [Abstract][Full Text] [Related]
6. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289 [TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545 [TBL] [Abstract][Full Text] [Related]
10. Methylprednisolone in acute spinal cord injury: is there any other ethical choice? Rozet I J Neurosurg Anesthesiol; 2008 Apr; 20(2):137-9. PubMed ID: 18362777 [No Abstract] [Full Text] [Related]
13. Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone. Young W; DeCrescito V; Flamm ES; Blight AR; Gruner JA Clin Neurosurg; 1988; 34():675-97. PubMed ID: 3378379 [No Abstract] [Full Text] [Related]
14. Methylprednisolone and other confounders to spinal cord injury clinical trials. Sipski ML; Pearse DD Nat Clin Pract Neurol; 2006 Aug; 2(8):402-3. PubMed ID: 16932592 [No Abstract] [Full Text] [Related]
15. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned]. Kronvall E; Sayer FT; Nilsson OG Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768 [TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone for the treatment of acute spinal cord injury: counterpoint. Fehlings MG; Wilson JR; Cho N Neurosurgery; 2014 Aug; 61 Suppl 1():36-42. PubMed ID: 25032529 [No Abstract] [Full Text] [Related]
18. Methylprednisolone for the treatment of acute spinal cord injury: point. Hurlbert RJ Neurosurgery; 2014 Aug; 61 Suppl 1():32-5. PubMed ID: 25032528 [No Abstract] [Full Text] [Related]
19. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med; 1990 Oct; 323(17):1207-9. PubMed ID: 2278580 [No Abstract] [Full Text] [Related]
20. Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy. Fehlings MG Spine (Phila Pa 1976); 2001 Dec; 26(24 Suppl):S56-7. PubMed ID: 11805611 [No Abstract] [Full Text] [Related] [Next] [New Search]